Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Apr 18:15:1377221.
doi: 10.3389/fimmu.2024.1377221. eCollection 2024.

Commentary: Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma

Zhongling Sun  1 , Ran Tan  2 , Huanling Wu  3 , Xiaosheng Fang  2
Affiliations
Comment

Commentary: Flow cytometry quantification of tumor-infiltrating lymphocytes to predict the survival of patients with diffuse large B-cell lymphoma

Zhongling Sun et al. Front Immunol. .
No abstract available

Keywords: DLBCL; TIL; TIL-B; TME; clinical decision support tool; flow cytometry; prognosis; tumor-infiltrating lymphocytes.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Schematic illustration of the prognostic values of tumor-infiltrating immune cells by flow cytometry analysis in a recent study (Ref. 6) by Yu et al. in Front Immunol 2024, Volume 15, doi: 10.3389/fimmu.2024.1335689. In that study, cell populations were identified and quantified by various antibody panels and different gating strategies by clinical workups according to the Duke Clinical Flow Cytometry Laboratory Standard of Operating Procedures in 2011-2022, and this figure only lists key markers used to identify different immune cell types as summarized in Reference .
See this image and copyright information in PMC

Comment on

Similar articles

See all similar articles

References

    1. Thommen DS, Schumacher TN. T cell dysfunction in cancer. Cancer Cell. (2018) 33:547–62. doi: 10.1016/j.ccell.2018.03.012 - DOI - PMC - PubMed
    1. Tilsed CM, Fisher SA, Nowak AK, Lake RA, Lesterhuis WJ. Cancer chemotherapy: insights into cellular and tumor microenvironmental mechanisms of action. Front Oncol. (2022) 12:960317. doi: 10.3389/fonc.2022.960317 - DOI - PMC - PubMed
    1. Zhang Y, Zhang Z. The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications. Cell Mol Immunol. (2020) 17:807–21. doi: 10.1038/s41423-020-0488-6 - DOI - PMC - PubMed
    1. Singh AP, Courville EL. Advances in monitoring and prognostication for lymphoma by flow cytometry. Clin Lab Med. (2023) 43:351–61. doi: 10.1016/j.cll.2023.04.010 - DOI - PubMed
    1. Li W. Flow cytometry in the diagnosis of leukemias. In: Leukemia [Internet]. Brisbane (AU): Exon Publications. (2022) Chapter 4. doi: 10.36255/exon-publications-leukemia - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources